Intellia Therapeutics (NTLA) Return on Sales [ROS] (2015 - 2026)
Intellia Therapeutics (NTLA) recorded Return on Sales [ROS] of -1472.25% in Q2 2026, down 700.08 percentage points from -772.17% a year earlier and down 804.18 percentage points from the prior quarter.
Intellia Therapeutics (NTLA) Return on Sales [ROS] (2015 - 2026) Analysis & Trends
On a TTM basis, Intellia Therapeutics' Return on Sales [ROS] came in at -711.66% as of Jun 30, 2026, up 257.03 percentage points year-over-year; for FY2025, it was -651.67%, up 271.43 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of -416.16 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -923.10% in FY2024 (+497.41 pp), -1420.51% in FY2023 (-541.47 pp), -879.04% in FY2022 (-68.67 pp) and -810.37% in FY2021 (-574.85 pp).
- The Q2 2026 figure is the lowest quarterly Return on Sales [ROS] since Q3 2024.
- On a year-over-year basis, Return on Sales [ROS] rose in five of the last eight quarters, with an average year-over-year change of +191.04 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1226.43 percentage points in Q2 2025, against a drop of 1025.13 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -668.08% (Q1 2026), -428.86% (Q4 2025) and -808.86% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Intellia Therapeutics | 1.57 Bn | -171.10 Mn | - | -1,707.73% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,707.73% |
| Jun 30, 2026 | -1,472.25% |
| Mar 31, 2026 | -668.08% |
| Dec 31, 2025 | -428.86% |
| Sep 30, 2025 | -808.86% |
| Jun 30, 2025 | -772.17% |
| Mar 31, 2025 | -726.57% |
| Dec 31, 2024 | -1,059.86% |
| Sep 30, 2024 | -1,588.96% |
| Jun 30, 2024 | -1,998.61% |
| Mar 31, 2024 | -394.00% |
| Dec 31, 2023 | -1,420.51% |
| Sep 30, 2023 | -1,093.29% |
| Jun 30, 2023 | -973.47% |
| Mar 31, 2023 | -888.13% |
| Dec 31, 2022 | -811.07% |
| Sep 30, 2022 | -795.49% |
| Jun 30, 2022 | -700.65% |
| Mar 31, 2022 | -1,281.96% |
| Dec 31, 2021 | -625.60% |
Intellia Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();